BISPECIFIC ANTIBODIES TARGETING BCMA AND CD28

The present invention relates to new humanized BCMA antibodies and bispecific antibodies that specifically bind to BCMA and CD28, methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same. La présente invention concerne de nouveaux anticorps...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MARBAN-DORAN, Celine, GREVYS, Algirdas, BIEHL, Marlene, BUJOTZEK, Alexander Christian, KLEIN, Christian, CARPY GUTIERREZ CIRLOS, Alejandro, KRUEGER, Julia, UMAÑA, Pablo, ECKMANN, Jan, LORENZ, Stefan, FAUTI, Tanja, HAGE, Carina
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to new humanized BCMA antibodies and bispecific antibodies that specifically bind to BCMA and CD28, methods for their production, pharmaceutical compositions containing these antibodies, and methods of using the same. La présente invention concerne de nouveaux anticorps BCMA humanisés et des anticorps bispécifiques qui se lient spécifiquement à BCMA et CD28, des procédés pour leur production, des compositions pharmaceutiques contenant ces anticorps, et des méthodes d'utilisation associées.